|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.720 SEK | -2.57% |
|
-4.18% | -35.41% |
| 06-16 | Vivesto AB Reports Positive Results From Intravenous Cantrixil Pharmacokinetic And Toxicology Study | CI |
| 06-16 | Vivesto reports positive results for intravenous Cantrixil | FW |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 17 | 17 | 24.9 |
| Spread/Res. | -48.71% | -48.71% | -64.98% |
| Spread/Supp. | +14.59% | +14.59% | +12.66% |
| Support | 7.61 | 7.61 | 7.74 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VIVE Stock
- Charts Vivesto AB
Select your edition
All financial news and data tailored to specific country editions
